(Q48754521)

English

Is the polymorphic microsatellite repeat of the dopamine beta-hydroxylase gene associated with biochemical variability of the catecholamine pathway in schizophrenia?

scientific article published in April 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9084894

Is the polymorphic microsatellite repeat of the dopamine beta-hydroxylase gene associated with biochemical variability of the catecholamine pathway in schizophrenia? (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9084894

0 references

1 reference

based on heuristic

inferred from title

author name string

Wei J

1

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9084894

Xu HM

2

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9084894

Ramchand CN

3

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9084894

Hemmings GP

4

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9084894

language of work or name

0 references

publication date

1 April 1997

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9084894

Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9084894

41

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9084894

7

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9084894

762-767

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9084894

Negative v positive schizophrenia. Definition and validation.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900218-1

7 January 2021

Methodological considerations in the determination of plasma catecholamines by high-performance liquid chromatography with electrochemical detection.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900218-1

7 January 2021

The significance of age of onset for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900218-1

7 January 2021

Schizophrenia: instability in norepinephrine, serotonin, and gamma-aminobutyric acid systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900218-1

7 January 2021

Gender and schizophrenia: implications for understanding the heterogeneity of the illness

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900218-1

7 January 2021

Brain catecholamines in schizophrenia -- a good case for noradrenaline.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900218-1

7 January 2021

Age at onset in schizophrenia. A familial perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900218-1

7 January 2021

Dinucleotide repeat polymorphism at the human dopamine beta-hydroxylase (DBH) locus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900218-1

7 January 2021

Aberrant monoamine metabolite levels in CSF and family history of schizophrenia. Their relationships in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900218-1

7 January 2021

Relationships in Healthy Volunteers Between Concentrations of Monoamine Metabolites in Cerebrospinal Fluid and Family History of Psychiatric Morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900218-1

7 January 2021

Possible Etiology of Schizophrenia: Progressive Damage to the Noradrenergic Reward System by 6-Hydroxydopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900218-1

7 January 2021

Schizophrenia: Dopamine β-Hydroxylase Activity and Treatment Response

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900218-1

7 January 2021

Heterogeneity of schizophrenia. Conceptual models and analytic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900218-1

7 January 2021

Studies on concentrations of NA and HVA and activity of DBH in the serum from schizophrenic patients, first-degree relatives and normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900218-1

7 January 2021

Studies on neurochemical heterogeneity in healthy parents of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900218-1

7 January 2021

Low concentrations of serum tyrosine in neuroleptic-free schizophrenics with an early onset

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2896%2900218-1

7 January 2021

Identifiers

10.1016/S0006-3223(96)00218-1

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9084894

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 February 2018

http://europepmc.org/abstract/MED/9084894

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48754521&oldid=1525229975"